Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
Reduction of interval cancer: in aggregate, the MASAI trial observed a large increase in cancer detection (29% increase in ...
Telesurgery (operating on a patient remotely using a surgical robot via a secure telecommunication link) appears to be as ...
Artificial intelligence helps doctors spot more cases of breast cancer when reading routine scans, a world-first trial found ...
The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. Local ...
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-controlled trial evaluating whether ...
The initiation of patient enrolment in the STARS DAPT trial marks an important milestone for Abluminus np. While contemporary ...
Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Patients with radiologically staged T3-4, N0-2, M0 colon cancer were randomly allocated (2:1) to 6 weeks oxaliplatin-fluoropyrimidine preoperatively plus 18 postoperatively (NAC group) or 24 weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results